Lithium Prescribing and Monitoring in Clinical Practice – A Practical Guide
Time to read: 10 minutes
In 2016, Kessing and colleagues published data on the prescription patterns of patient’s who were first diagnosed with bipolar disorder. 
Major changes were reported with drug prescription choices over the period from 2000 to 2011 with antiepileptic and atypical antipsychotics were prescribed substantially more than lithium, despite lithium having a substantial evidence base as a mood stabiliser with proven efficacy in acute mania, long-term prophylaxis of bipolar disorder and to a lesser extent in depressive disorders.
We covered the neuroprotective effect of lithium and a summary of its mechanism of action in a previous article.
In this article, we focus on the practical aspects of prescribing lithium in clinical practice.